RESUMEN
Objective To explore the value of clinical application of high intensity focused uitrasound (HIFU)supplementary treatment evaluated and instructed by immediate contrast-enhanced uitrasound for Drimary hepatic carcinoma.Methods Fifty-five cases(68 lesions)of hepatocellular carcinoma(HCC)were randomized into 2 groups,30 cases(38 lesions)in group A and 25 cases(30 lesions)in group B.Patients of group A were examined by contrast-enhanced ultrasound before and after therapy in 10 minutes.The lesions of incomplete deactivation were treated by HIFU in time.The treatment security and the therapeutic effects were observed by the clinical symptom,serum AFP and imaging appearance.The long-term therapeutic effects were judged by follow-up survival rate.Results Nineteen lesions in group A were found incomplete deactivation and run supplementary treatment in time.No serious complication was identified.The AFP descending rate was 86.7%(26/30)in group A,64.0%(16/25)in group B,respectively(P＜0.05),and the lesions complete necrosis rate was 97.3%(37/38),60.0%(1 8/30),respectively(P＜0.05).Half year survival rate was 100%in group A,90.0%ih grouD B(P＜0.05),and 1 year survival rate was 76.0%,68.0%,respectively(P＜0.05).Conclusions HIFU supplementary treatment evaluated and instructed by immediate contrast-enhanced ultrasound for primary hepatic carcinoma can help to destroy the lesions completely,alleviate the symptom,reduce recurrence,improve life quality,lengthen the lifcrime,and has the better clinical practice value.
RESUMEN
The current situation of the rise in medical expenses is shown through statistics and the causes of the rise are analyzed. These include: ①inevitability of development, such as changes in the spectrum of diseases, use of new technologies and materials, rise in the overall price index, and generally increased needs for medical care; ②restriction of social factors, such as the imperfect medical insurance system, the reduced proportion of input by the government, the irrational medical pricing and compensation, the fictitiously high pricing of drugs and health materials, and the hospital's excessively high operational costs; ③the boosting effect of the "supporting medicine with drugs" policy. Countermeasures are put forward for the government's price control and financial organs, the departments of health administration, and the hospitals.